Resultats globals: 2 registres trobats en 0.03 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
16 p, 1.1 MB The New Era for Reno-Cardiovascular Treatment in Type 2 Diabetes / García-Carro, Clara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vergara, Ander (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Agraz Pamplona, Irene (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Jacobs-Cachá, Conxita (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Espinel Garuz, Eugenia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Seron, Daniel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Soler, María José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease in the developed world. Until 2016, the only treatment that was clearly demonstrated to delay the DKD was the renin-angiotensin system blockade, either by angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. [...]
2019 - 10.3390/jcm8060864
Journal of clinical medicine, Vol. 8 (june 2019)  
2.
20 p, 8.4 MB New insights into the mechanisms of action of topical administration of GLP-1 in an experimental model of diabetic retinopathy / Sampedro, Joel (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Solà-Adell, Cristina (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Turch, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Valeri, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó-Servat, Olga (Universitat Autònoma de Barcelona. Departament de Medicina) ; Lagunas, Carmen (Ferrer Advanced Biotherapeutics) ; Simó Canonge, Rafael (Universitat Autònoma de Barcelona. Departament de Medicina) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bogdanov, Patricia (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Ramos, Hugo (Hospital Universitari Vall d'Hebron. Institut de Recerca)
The main goals of this work were to assess whether the topical administration of glucagon-like peptide-1 (GLP-1) could revert the impairment of the neurovascular unit induced by long-term diabetes (24 weeks) in diabetic mice and to look into the underlying mechanisms. [...]
2019 - 10.3390/jcm8030339
Journal of clinical medicine, Vol. 8 (2019) , p. 1-20  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.